Neuro-Oncology Program

Neuro-Oncology team members at Moffitt

The Neuro-Oncology Program at Moffitt Cancer Center, led by Chair Peter Forsyth, MD, and Program Leader Michael Vogelbaum MD, PhD, offers a full range of diagnostic and treatment services at a single location. Our Neuro-Oncology specialists offer a variety of innovative treatments to patients with brain and spine malignancies, including chemotherapy, radiation therapy, immunotherapy and neurosurgical options ranging from minimally invasive procedures to even the most complex awake craniotomies. Eligible Moffitt patients may also have the opportunity to participate in a clinical trial, where they may benefit from innovative therapies before they are made available elsewhere.

Coordinated, Multidisciplinary Care

Referring physicians who entrust their patients to Moffitt's Neuro-Oncology Program are securing for them the highest caliber of medical attention. Within our advanced program, we have disease-specific specialists in the fields of:

Learn more about the Neuro-Oncology Program Team

One of the hallmarks of the coordinated, multidisciplinary care at Moffitt is the Neuro-Oncology Tumor Board. Our multi-specialty tumor board meets each week to determine and coordinate the best treatment approach for each patient, also taking into account the patient’s unique genetic makeup. The Neuro-Oncology Tumor Board also considers which investigational agents are available for each patient, particularly for those patients where the diagnosis has few or no cures. As a result of this comprehensive approach, Moffitt's Neuro-Oncology Program consistently achieves outcomes that are better than or comparable to the national averages.

A Wide-Array of Treatment Options

Through this diverse group of specialists who collaborate on each patient's cancer treatment, Moffitt delivers the most advanced therapies with exceptional skill while also offering compassionate supportive care. Even the most complex procedures, such as awake craniotomies and minimally-invasive cranial and spinal surgery are performed in substantial numbers at Moffitt. Other innovative offerings include routine and investigational chemotherapy infusions, gene therapies, and immunotherapy, as well as a state-of-the-art stereotactic radiosurgery program for tumors of the brain and spine.

Clinical Trials

Advances in understanding the biology of cancer, and efforts to develop new, more effective therapeutics, ultimately result in the development of novel treatments. These treatments are provided to patients initially in clinical trials and Moffitt Cancer Center has one of the largest clinical trial programs in cancer in the nation. Clinical trials within the Neuro-Oncology Program include investigations into:

  • New ways to use immunotherapy to fight brain cancer
  • Gene therapy for brain cancer
  • Treatment of leptomeningeal disease (LMD), which currently has few effective treatments
  • Use of personalized approaches to match the treatment to the genetics of a patient’s tumor
  • Direct delivery of novel therapeutics to tumor tissue

To learn more about the clinical trials currently available at Moffitt, contact us at 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.


Moffitt provides detailed records to help keep referring physicians updated on their patients’ progress. And, to facilitate further communication between referring physicians and Moffitt's neuro-oncologists, our clinic offers a 24/7 hotline for questions and record requests.

To refer a patient to Moffitt's Neuro-Oncology Program, complete our online form or contact a physician liaison for assistance or support. Virtual Visits appointments are available.  

Online referrals are typically responded to within 24 – 48 hours. 

Medically Reviewed by Dr. Michael Vogelbaum, Program Leader, Department of Neuro-Oncology.